Reconnecting Practicing Hygienists with the Nation's Leading Educators and Researchers.

FDA Approved Daytime Device for Treatment of OSA

The US Food and Drug Administration (FDA) has approved a prescription-only daytime device for the treatment of mild obstructive sleep apnea (OSA). 

The US Food and Drug Administration (FDA) has approved a prescription-only daytime device for the treatment of mild obstructive sleep apnea (OSA). 

The eXciteOSA device is designed to be worn during the day to reduce snoring and mile OSA that aims to improve tongue muscle function by delivering electrical muscle stimulation through a mouthpiece that sits around the wearer’s tongue. The eXciteOSA mouthpiece has four electrodes, two located above the tongue, and two located below the tongue. Designed for patients who are 18 years and over, the device is worn for 20 minutes a day, for a period of 6 weeks and once a week thereafter, according to the FDA.

Read more about the device here:  fda.gov/news-events/press-announcements.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy